Business Wire·May 7, 2026, 4:02 PM ET

Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance

CDLX

Cardlytics announced first quarter 2026 financial results with revenue from continuing operations of $34.3 million.
Billings from continuing operations totaled $58.1 million, while adjusted contribution from continuing operations was $19.7 million.
The company successfully completed the divestiture of Bridg on March 24, 2026, with subsequent liquidation of PAR shares to bolster the balance sheet.
Net loss for the quarter was $4.5 million, or $0.08 per diluted share, compared to a net loss of $13.3 million in the same period of 2025.
Adjusted EBITDA turned positive at $0.2 million, up from a loss of $4.1 million in the first quarter of 2025.
Monthly qualified users (MQUs) decreased 8% year-over-year to 197.0 million, while adjusted contribution per user (ACPU) fell to $0.10 from $0.13.
Free cash flow for the quarter was $(7.9) million, an improvement from $(10.8) million in the prior year period.
For the second quarter of 2026, the company guided billings to be between $61.0 million & $67.0 million.
Revenue guidance for Q2 2026 is set between $35.0 million & $40.0 million, with adjusted contribution expected between $20.0 million & $23.0 million.
Adjusted EBITDA for Q2 2026 is projected to range from a loss of $2.7 million to a profit of $1.3 million.
CEO Amit Gupta stated that the first quarter marked a shift from stabilization to execution, noting the company exceeded the midpoint of its guidance range across all key metrics.
The company's cash & cash equivalents balance decreased to $35.7 million at March 31, 2026, from $48.7 million at the end of 2025.
Total liabilities stood at $267.9 million, resulting in a total stockholders' deficit of $4.0 million as of the end of the quarter.